Position in HLN
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$8,188
-$81 QoQ
Shares Held
818
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Westside Investment Management, Inc. holds $18,388,670 across 12 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ETON |
Eton Pharmaceuticals, Inc.
|
467,915 | $11,548,142 | |
| 2 | HROW |
Harrow, Inc.
|
185,926 | $6,555,750 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
5,000 | $150,600 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
4,650 | $64,401 | |
| 5 | VTRS |
Viatris Inc
|
2,297 | $31,031 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,500 | $14,280 | |
| 7 | HLN |
Haleon plc
This page
|
818 | $8,188 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
1,025 | $6,631 |
All Filings in HLN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,188 | 818 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $8,269 | 818 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,337 | 818 | Shares | Sole | 2025-11-04 | |
| 2024-03-31 | $297 | 35 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $288 | 35 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $291 | 35 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $293 | 35 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $284 | 35 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $280 | 35 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $213 | 35 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||